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a  b  s  t  r  a  c  t
Studies  on Variant  Surface  Glycoproteins  (VSGs)  and  antigenic  variation  in the  African  trypanosome,
Trypanosoma  brucei,  have  yielded  a remarkable  range  of  novel  and important  insights.  The  features  first
identified in  T. brucei  extend  from  unique  to  conserved-among-trypanosomatids  to  conserved-among-
eukaryotes.  Consequently,  much  of  what  we now  know  about  trypanosomatid  biology  and  much  of the
technology  available  has  its  origin  in studies  related  to  VSGs.  T.  brucei  is now  probably  the  most  advanced
early  branched  eukaryote  in  terms  of experimental  tractability  and  can  be approached  as  a  pathogen,  as  a
model for  studies  on  fundamental  processes,  as  a model  for studies  on  eukaryotic  evolution  or  often  all  of
the  above.  In terms  of  antigenic  variation  itself,  substantial  progress  has  been  made  in understanding  the
expression  and  switching  of the VSG  coat, while  outstanding  questions  continue  to  stimulate  innovative
new  approaches.  There  are  large  numbers  of VSG  genes  in the  genome  but  only  one  is expressed  at  a
time,  always  immediately  adjacent  to  a  telomere.  DNA  repair  processes  allow  a new  VSG  to be  copied
into the single  transcribed  locus.  A  coordinated  transcriptional  switch  can  also  allow  a new  VSG  gene  to  be
activated  without  any  detectable  change  in  the  DNA  sequence,  thereby  maintaining  singular  expression,
also  known  as allelic  exclusion.  I review  the  story  behind  VSGs;  the  genes,  their  expression  and  switching,
their  central  role  in  T.  brucei  virulence,  the  discoveries  that  emerged  along  the  way  and  the persistent
questions  relating  to allelic  exclusion  in  particular.
©  2014  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license
(http://creativecommons.org/licenses/by/3.0/).
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1. Introduction
Variant Surface Glycoproteins (VSGs) are developmentally
regulated genes that mediate immune evasion. Activated in the
tsetse-fly salivary-gland [1], and inactivated upon return to the
tsetse-fly mid-gut, they produce a protective cell coat throughout
the mammalian infectious cycle. The coat must provide robust
∗ Tel.: +44 (0) 1382 386 286.
E-mail address: d.horn@dundee.ac.uk
protection as Trypanosoma brucei occupy the bloodstream and
tissue-spaces of their hosts and are fully exposed to immune
surveillance in this hostile environment. Indeed, as an infection
persists, the vast majority of the parasite population is periodi-
cally eliminated. The key features underlying successful immune
evasion are clone-specific singular VSG expression combined with
switching from one VSG to another. The metacyclic cells in the
salivary gland are challenging to study since VSG expression is
heterogeneous during this phase and the yield of T. brucei from
flies is limiting. Most studies, therefore, have been conducted using
bloodstream forms, more recently in axenic culture. Antigenic
http://dx.doi.org/10.1016/j.molbiopara.2014.05.001
0166-6851/© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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variation continues to operate in this environment [2] indicating
that host antibodies are selective rather than a trigger for variation.
An advantage here is that VSG switching operates at a frequency of
approximately 1 switch/105 cells per population doubling, allowing
the analysis of almost homogeneous but switchable populations.
Many seminal discoveries have emerged from studies on VSGs
in T. brucei and the drive to understand VSGs and their expression
has also led to the development of many of the tools and technolo-
gies now available for a range of other studies on trypanosomatids.
Indeed, studies on VSG expression revealed much of what we now
know about gene expression in trypanosomatids. Some features are
specific to VSG gene expression sites, while others operate across
the genome and are conserved in trypanosomatids that do not
express VSGs. Thus, work on VSGs has informed studies on other
important parasites, including Trypanosoma cruzi and Leishmania
species. VSGs in T. b. gambiense,  T. b. rhodesiense, T. equiperdum, T.
congolense and T. vivax are not discussed in detail here but a sim-
ilar system of gene expression and antigenic variation appears to
operate in T. brucei brucei and in these other African trypanosomes.
What I present below is a somewhat historical perspective on
antigenic variation in T. brucei and, in this regard, I recommend
further reading of some of the older papers in particular, not often
cited these days but often impressive when viewed in this historical
context. It is also worth noting that few studies on antigenic vari-
ation in T. brucei have been or are currently specifically focussed
on the prospect of a therapy in the short term. The central role of
VSGs in virulence does mean that improved knowledge in this area
is likely to present further opportunities for intervention, however.
2. A very brief early history – pre VSG gene-cloning
Sir David Bruce had read David Livingstone’s reports on the
tsetse fly diseases known as nagana in cattle and sleeping sickness
in humans and, while searching for the cause more than 100 years
ago, reported that“ a rapidly moving object was seen lashing about
among the red blood corpuscles . . . probably a trypanosome” [3].
Bruce also noted “the parasites come and go in the blood” and
Franke & Ehrlich had deduced in 1905 that T. brucei acquired prop-
erties that conferred resistance to host “defensive substances”.
Ronald Ross and others then enumerated the relapsing para-
sitaemia in patients [4], albeit treated with several different drugs
during monitoring in this case. A number of parasitic infections
of mammals are now known to display relapses due to the emer-
gence of new variants that are no longer susceptible to the latest
host immune response (Fig. 1A).
In the 1960s, Keith Vickerman’s work using electron microscopy
revealed the dense T. brucei coat responsible for clone-specific
relapses [5]. The identification and purification of the coat proteins
by George Cross followed in the 1970s [6] and then the cloning
and sequencing of the corresponding cDNA in the late 1970s and
early 1980s (detailed below). The VSG responsible for clone-specific
immunity or antigenic variation were found to be Variant through-
out much of their length, they were known to represent the major
component of the trypanosome Surface coat and they were Glyco-
proteins, decorated with multiple sugar residues [6].
3. The variant surface glycoprotein coat
The 15 nm thick VSG coat covers the entire cell and is an
essential virulence factor. Formed from approximately 10 million
molecules of approximately 60 kDa, the coat represents up to 20%
of total cell protein [6], facilitating the production of antisera that
recognise distinct VSGs [7]. VSGs are present at the cell surface
as homodimers and, despite extreme sequence divergence, dis-
play remarkably similar structures [8], partly due to a conserved
Fig. 1. VSG expression and switching. (A) VSG switching brings about antigenic
variation. Combined with successive immune responses, this can generate a relaps-
ing  parasitaemia. Natural infections are more complex than this highly simplified
schematic. (B) Studies on VSG expression revealed some unusual features. The sin-
gle expressed VSG was found to be flanked by distinct repetitive sequences. Three
further unusual features are indicated (boxes).
arrangement of disulphide bonds. Coat exchange during a VSG-
switch appears to be primarily by dilution during cell division since
cells divide approximately every 6 h with shedding and turnover
being relatively much slower [9]. Cytokinesis is in fact dependent
upon VSG supply as demonstrated by knockdown experiments
[10]. The VSG is not a transmembrane protein but is rather anchored
in the membrane by glycosylphosphatidylinositol (GPI). Indeed, GPI
was discovered in T. brucei and this yielded the first GPI  structure
[11] as well as a description of GPI biosynthesis [12]. GPI anchors
were subsequently discovered in mammals and in other cells [13]
but the biosynthetic pathways do display differences [14].
The fluid nature of the VSG coat allows for a remarkably high
rate of recycling involving endocytosis at the flagellar pocket [15].
This allows the coat to be cleansed of antibodies, at low titre at
least, and this requires vigorous directional cell motility mediated
by the flagellum [16]. VSG coats are highly immunogenic however,
so once antibody titre increases, the vast majority of parasites are
eliminated and only cells with distinct VSG coats survive. As well
as this variable function, the VSG coat also serves to protect less
variable or even invariant surface proteins from immune effectors.
Comparison of the genome sequences of T. brucei,  T. congolense and
T. vivax revealed not only how VSG repertoires evolved [17] but also
allowed reconstruction of a surface phylome [17]. This revealed
a diversity of potential non-VSG surface proteins, nutrient recep-
tors and other ‘invariant’ surface glycoproteins. It appears that the
densely packed and thick VSG coat can physically obstruct access
to these proteins by conventional immunoglobulins while selec-
tively allowing access to smaller molecules such as nutrients [18].
Nanobodies also have the potential to access the less variable epi-
topes usually hidden within the coat by the size exclusion limit
[19].
4. VSG genes and their subtelomeric environment
Access to the first cloned VSG genes provided probes to explore
copy number, location and diversity within trypanosome genomes,
especially because the 3′ terminal regions of VSG mRNAs were
found to be conserved [20]. It was  soon recognised that the single
expressed VSG was adjacent to a telomere, or a chromosome dis-
continuity that was subject to Bal31 exonuclease digestion [21,22]
and this strict association remains intact to date (Fig. 1B). This
stimulated much interest in telomere biology in trypanosomes,
D. Horn / Molecular & Biochemical Parasitology 195 (2014) 123–129 125
which revealed the addition (and occasional large deletions) of
TTAGGG/CCCTAA-repeats to growing telomeres [23–25]; the same
hexameric repeats were later found at human telomeres. T. brucei
telomeres were also found to terminate in t-loops [26] and this was
followed by the identification and characterisation of telomerase
reverse transcriptase, responsible for telomere growth, and other
telomere-repeat-binding proteins [27].
The VSG-telomere association actually goes much further. Each
T. brucei genome contains around 250 telomeres, almost all of
which may  be closely linked to non-transcribed VSG genes, with
their 3′-ends closest to the telomere. Around 80% of these telomeres
reside on 50–100 kbp long minichromosomes [22,28,29], which
appear to be entirely dedicated to VSG archiving. Another ten
or so telomeres reside on ‘intermediate’ chromosomes and the
remaining 44 reside on the eleven pairs of megabase-chromosomes
that comprise the diploid genome. With many additional arrays
of subtelomeric VSGs, it is currently thought that up to 30% of an
African trypanosome genome is dedicated to archiving up to 2000
VSG genes and gene-fragments.
Although the size of the VSG archive and the telomeric envi-
ronment continue to present challenges for complete genome
assembly and functional analyses, important insights into VSG gene
evolution and diversification have emerged from genome sequenc-
ing [30] and the cloning and sequencing of large intact telomeric
fragments [31]. Extensive hemizygous subtelomeric domains on
the megabase chromosomes are dedicated to arrays of archival VSGs
[32], meaning that many VSGs are present as a single copy even in
a diploid genome. Most of these VSGs are pseudogenes in T. brucei
(749/804 analysed) and these VSGs are flanked by 70-bp repeats
(Fig. 1B) upstream [33] and highly conserved elements within the
3′-untranslated region (3′-UTR); both of these sequences facilitate
recombination (see below). The 3′-UTR is also involved in specific
stabilisation of the VSG mRNA at the bloodstream stage, contribut-
ing to a half-life of 4.5 h [34].
5. VSG gene expression – trans-splicing and polycistronic
Pol I transcription
The ‘yeast to human’ view of eukaryotic diversity is very narrow
so it is not surprising that several dogmas have been overturned
by work on the divergent trypanosomes. Studies on VSGs revealed
some unusual features underlying gene-expression in trypanoso-
matids for example (Fig. 1B). S1 nuclease protection and RNA
blotting experiments revealed a spliced segment at the 5′ end of the
VSG mRNA and reverse transcription then showed this “mini-exon”
or “spliced leader” sequence to be 35 nt long [35]. Intriguingly, the
same sequence was found at the 5′-end of two other VSG mRNAs
[36]. Cis-splicing was initially considered to be the most likely
explanation but it turned out that this same sequence was  present
on all mRNAs. In fact, discontinuous mRNA synthesis through
bimolecular splicing or trans-splicing allows mature mRNA to be
derived from precursor RNAs transcribed from two  different chro-
mosomes [37]. Trans-splicing was also found to operate in other
trypanosomatids [38] and in nematodes.
The search for a VSG gene promoter extended further from the
gene itself than expected. In most eukaryotes, each gene has its own
promoter, while polycistrons are largely restricted to prokaryotes.
Cloning and mapping upstream of an active VSG revealed a large
expanse of imperfect 70-bp repeats [39] and then an Expression
Site Associated Gene or ESAG [40] and then several more ESAGs
[41] forming a polycistron. It was found that -amanitin failed
to inhibit ribosomal RNA (rRNA) transcription, as expected, but
also VSG transcription [42] implicating RNA Pol I. These findings
prompted a detailed analysis of RNA pol I and associated factors in
T. brucei (see below). Polycistronic transcription was also found to
operate within Pol II transcription units elsewhere in the genome
[43] and this has proven to be a pervasive feature of trypanoso-
matid genomes. As for the VSG expression site promoter, the first
one was eventually found around 60 kbp from the VSG [44] and was
indeed, following mounting evidence, confirmed to recruit RNA Pol
I in vitro [45]. Nuclear ‘run-on’ assays combined with inhibition
of transcription elongation using UV exposure were instrumental
in locating the VSG expression site promoter [46], the sequence
of which was unrelated to the more conventional rDNA promoter
[47]. The metacyclic promoters responsible for VSG transcription
in the tsetse-fly salivary gland were also found to recruit RNA Pol I
but were distinct from the bloodstream promoters and in this case
were located only a short distance upstream of the telomeric VSGs
[48]; these are among only a few monocistronic transcription units
in trypanosomatids.
The result of all this work revealed a somewhat surprising sit-
uation whereby RNA Pol I and RNA Pol II are required to produce
mature VSG expression site transcripts; transcription of the spliced
leader sequence was  confirmed to be RNA Pol II dependent [49].
Further surprises were in store as assessment of other potential Pol
II promoters in T. brucei or in other trypanosomatids failed to yield
any further conventional examples. Rather, around sixty RNA Pol
II ‘transcription initiation sites’ appear to depend upon a partic-
ular chromatin structure [50] that is not readily reconstituted on
reporter constructs.
Fifteen copies of the highly conserved subtelomeric VSG expres-
sion sites active in the bloodstream have now been identified,
cloned by recombination in yeast and sequenced from the most
widely studies T. brucei strain [31]. Present on the diploid and
intermediate-chromosomes, these contain intact promoters and
are competent transcription units but are typically reversibly
repressed due to monoallelic VSG expression control. Many ESAGs
found within these polycistronic units remain to be characterised
but the evidence so far points to roles in host-parasite interactions.
For example, a novel heterodimeric transferrin receptor, encoded
by ESAG6 and ESAG7 and related to the N-terminal domain of the
VSG, has the capacity to bind transferrin from different hosts with
different affinities [51]. A human serum resistance associated gene,
or SRA, found in T. brucei rhodesiense, also resembles a VSG and is also
an ESAG [52] while another gene resembling a VSG, known as TgsGP,
confers human-serum resistance to T. brucei gambiense [53]. ESAG4
genes are unrelated to VSGs, but also mediate host-parasite interac-
tions. These genes encode adenylate cyclases which are released by
lysed trypanosomes and inhibit the innate immune response [54].
Clearly, VSGs and their associated genes have been central to the
‘arms-race’ operating and evolving at the host-parasite interface.
The vast reservoir available has allowed VSG genes to be co-opted
to functions beyond classical antigenic variation. The relationships
among these proteins could equally reflect an evolutionary origin
of VSGs from ancient surface receptors.
6. Antigenic variation by VSG gene rearrangement
Subtelomeres are recombinogenic hotspots, plastic regions of
genomes enriched in gene families that are most commonly
involved in adaptation to different environments. Like many other
cell types, African trypanosomes appear to have exploited these
properties, in this case for the massive expansion and evolution of
the VSG family and also for the ESAGs [55]. Antigenic variation in T.
brucei involves switching to expression of a distinct VSG so the avail-
ability of VSG cDNA clones allowed researchers to look for changes
associated with the activation and inactivation of those VSGs. Early
analyses using Southern blotting [56,57], northern blotting [58],
DNAse I digestion [59] or DNA sequencing [60] revealed switch-
ing by duplicative transposition of a non-telomeric ‘basic copy’
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Fig. 2. DNA recombination is central to VSG switching. The active subtelomeric VSG
locus is prone to spontaneous DNA breaks. Three classes of repair templates are
shown with VSGs represented as coloured boxes; those sharing more (flanking)
homology with the active site are used more frequently (grey arrows). The homolo-
gous sequences indicated are the 70-bp repeats (blue stripes), the telomeric repeats
(black stripes), the VSG 3′-UTRs (thick black bars) and a portion of the VSG coding
sequence (red). A break in or around the active VSG is followed by DNA resection
extending towards the 70-bp repeats, often initiating recombination in this region.
VSG and replacement of the old VSG by the new ‘expression-linked
copy’ at a single transcribed locus. Silent telomeric VSG cassettes
appeared to be copied all the way to the end of the chromosome
[61,62] by a mechanism now known as ‘break-induced replication’
(BIR).
Subsequent analyses revealed a range of variations on the
recombination theme and DNA homology emerged as the key
driver of these VSG rearrangements [63] stimulating further stud-
ies on a range of T. brucei DNA-repair factors. Most VSGs are flanked
upstream by common 70-bp repeats and even non-telomeric genes
share sequences at the 3′-end [64], sometimes within the region
encoding the VSG C-terminal domain and almost always in the
conserved VSG 3′-UTR (Fig. 2). Replacement of larger parts of the
expression site or non-duplicative telomere exchange [65] can
bring about a switch but these events appear to be relatively
rare and even actively suppressed [66]. Translocation to the active
site is preferentially initiated by the long tracts of 70-bp repeats
found upstream of the active VSG [67,68] so the probability of
being ‘selected’ as a template for repair depends upon these and
other sequences shared with the active VSG locus [69]. Indeed,
70-bp repeat recombination is primarily responsible for the high-
efficiency duplication of telomeric VSGs [61,62], which can employ
the BIR mechanism, while chromosome-internal VSGs must use
a ‘gene-conversion’ mechanism, similar to BIR but with a second
recombination junction, most often within the VSG 3′-UTR [39,70].
Conversion of even shorter VSG segments can generate ‘mosaic’
VSGs that, because of their lower-frequency emergence, become
increasingly important for parasite persistence in a chronic infec-
tion [64,71–73], as immunity to more-frequently activated VSGs
builds [67].
This understanding of the shared sequences that drive recom-
bination can now explain why the expression of VSGs is
‘semi-ordered’ or somewhat predictable. Any order though will
be isolate-dependent, less predictable as the infection progresses
and will ultimately be highly dynamic and variable in different
infections and also from one epidemic to the next, meaning that
herd-immunity is unlikely to be achieved. The potential VSG reper-
toire is ultimately larger than a single genomic repertoire due to
segmental gene conversion and inter-strain mating in the tsetse fly
[74]. This genome plasticity also impacts the VSGs expressed in the
tsetse fly salivary gland and presents stark challenges in terms of
any vaccine strategy that targets VSGs.
VSG recombination does not appear to be naturally triggered
by a site-specific nuclease but rather appears to depend upon the
inherent instability of subtelomeres [75,76]. Breaks were shown to
arise naturally at telomeric VSG loci, probably due to replication
fork collapse, and an artificial, meganuclease-induced DNA break
at the active site can trigger a switch [75,77]. These breaks initiate
DNA resection producing ssDNA and triggering a homology search.
Once a suitable template is found, DNA can be copied from the tem-
plate to repair the lesion [76]. Non-homologous DNA repair does
not appear to operate in T. brucei,  placing an emphasis on RAD51-
dependent homologous recombination [63,78]. This has had a
major impact on our ability to manipulate the T. brucei genome
and also makes an important contribution to VSG gene rearrange-
ments. There is an alternative form of microhomology-mediated
end-joining, however. This end-joining is RAD51-independent and
may be particularly effective within 70-bp repeats, thereby making
a substantial contribution to the duplicative transposition of VSGs
[76].
Nuclear positioning and the chromatin environment of VSGs
may be important for VSG recombination [77]. In the bloodstream
form, telomeres [79], active [80] and silent VSG expression sites
[81] are distributed throughout the nuclear space rather than
sequestered at the periphery and this may  facilitate homology
searching during DNA repair. Notably, the active VSG expression
site specifically migrates to the nuclear periphery during differen-
tiation to the insect stage [82].
Switching occurs in only approximately 0.001% of cells per cell
division cycle in experimental in vitro culture or during frequent
syringe passage but appears to be much higher naturally; switch
rate returns to >0.2% following transmission through flies [83]
and also apparently increases during growth in vivo in mammals
[68,84]. This transition is not understood but could involve the
acquisition of a hyper-labile or hyper-recombinogenic state at the
active VSG locus [85]. Rapid switching also operates in metacyclic
cells obtained from tsetse-fly salivary glands [86] but in this case,
switching does not involve recombination [87].
The vast and dynamic VSG gene family, the large number of
subtelomeres in T. brucei and the incomplete sequence coverage
currently available for these regions presents challenges but cur-
rent techniques should now allow some longstanding questions
to be addressed. For example, where in the genome are often
entirely pseudogene-derived mosaic-VSGs assembled and presum-
ably selected for? Do non-templated VSG mutations [88] naturally
contribute to immune evasion? Are novel VSGs typically preserved
or permanently lost once successfully used for immune evasion? In
terms of this last question, the presence of intact VSGs on minichro-
mosomes [29] could reflect an effective archiving mechanism for
novel VSGs. It will also be of interest to determine whether VSG
recombination requires or exploits dedicated or specifically mod-
ified DNA repair factors, such as BRCA2 with an expanded set of
RAD51-interacting repeats [89].
7. Antigenic variation by VSG transcription (in)activation –
allelic exclusion
Studies on T. brucei clones with switched VSGs also revealed
that some switching events were not associated with duplicative
VSG transposition [90]. Pulsed-field gel-electrophoresis, combined
with Southern blotting, which had also facilitated ‘mapping’ of
the VSG rearrangements described above, provided confirmation
of coordinated on and off switching, known as ‘in situ’ switch-
ing [28]. This showed that certain telomeric VSGs were reversibly
active or repressed and could be subject to transcriptional switch-
ing as well as recombination [61,91]. The in situ switches are
classical epigenetic switches since they occur without changes in
the DNA sequence [44]. Thus, although gene expression control in
trypanosomatids is primarily post-transcriptional, VSG exclusion
represents a prominent exception (Fig. 3). Although simultaneous
expression of two  VSGs from distinct telomeric sites has been
reported in T. equiperdum [92], VSG double-expressors arose rarely
and were unstable in T. brucei [93]. Thus, VSG allelic exclusion is
generally strictly maintained.
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Fig. 3. VSG allelic exclusion is not yet understood. (A) Only one of the telomeric VSGs
(red  and green) is active and only in the mammalian stages. This associates with a
focus of extranucleolar RNA Pol I and other factors (light blue) and produces the VSG
coat (outer red box). The ‘+’ and ‘x’ symbols indicate the active and silent telomeres,
respectively. (B) Transcription can occasionally switch from one telomeric VSG to
another; a coordinated epigenetic switch maintains allelic exclusion. The dashed
arrow indicates transcription. Other details as in A.
The mechanism that distinguishes among almost identical VSG
expression sites in the bloodstream form suppresses both tran-
scription initiation [94] and elongation [95] and this results in a
remarkable 10,000-fold abundance differential among active and
silent VSG mRNAs [96]. Despite the distinct sequences of rDNA pro-
moters, these promoters, inserted at VSG expression sites, adopt the
transcriptional status of that site [97,98]. A second VSG inserted
at an active VSG expression site is similarly also active [99,100].
In contrast to this locus-specific control in the bloodstream form,
it seems that VSG promoter-specific elements, distinct from rDNA
promoters, allow selective down-regulation of all VSG transcription
during differentiation to the insect-stage [101].
A novel DNA base, the hydroxylated and glucosylated derivative
of thymidine or base-J [102], was first discovered at silent VSG loci.
Evidence of J-base came from blocked cleavage by certain restric-
tion enzymes such as PstI  as revealed on Southern-blots. Base-J is
notably absent from insect-stage T. brucei but, although implicated
for many years, no role in antigenic variation has been demon-
strated [103]. What is established is that J-base is required for RNA
Pol II transcription termination in L. major [104] so it remains possi-
ble that J-base also presents a barrier to certain RNA polymerases or
DNA polymerases in T. brucei,  potentially impacting transcription
or DNA recombination and repair, respectively.
Transcription of the single active VSG by RNA Pol I, rather than
RNA Pol II, suggested a potential ‘privileged domain’ model for acti-
vation based on association with the nucleolus. As it turned out,
active VSG transcripts and the active VSG locus were found to be
extranucleolar [81]. Like the nucleolus though, this region, known
as the expression-site body, is associated with an accumulation of
RNA Pol I [80], a trypanosomatid-specific transcription initiation
complex known as class I transcription factor A [105] and also a pol
I-associated high-mobility group factor [106].
It remains likely that the telomeric environment is important
for VSG allelic exclusion as well as for VSG recombination. There is
evidence of a role for the telomere-binding protein, RAP1, in VSG
silencing [96] and this silencing is also dependent upon chromatin
structure [107,108]; since this topic is covered in a recent review
[77] it is not covered in any detail here. Briefly, the histones, histone
chaperones, chromatin remodelers, chromatin modifiers, cohesins
and nuclear lamina, as well as other chromatin-associated factors,
contribute to repression. DOT1B in particular, has a major role in
establishing the silent state during in situ switching [109]. Thus,
transcription is clearly repressed or attenuated at telomeric VSG
loci. Understanding allelic exclusion will remain challenging until
we know more about the selection of a single VSG for expression
and how this is coordinated with the silencing of all other VSGs.
8. Concluding remarks
The abundance of the active VSG, quite stable yet reversible
VSG repression and the ease of genetic manipulation and cell cul-
ture mean that T. brucei provides a highly tractable experimental
system for the study of monoallelic expression and antigenic vari-
ation. There has been tremendous progress in our understanding
in this area, how the VSGs are organised and expressed and how
expression is switched, through recombination in particular. An
ancient and ongoing ‘arms race’ between host immunity and para-
site immune evasion has been illuminated through studies on VSGs.
The set of monocistronic VSGs first expressed in the tsetse-fly sali-
vary gland facilitates the establishment of a mammalian infection
following a blood-meal. The multiplicity of telomeric VSGs with
alternative collections of ESAGs may  then provide an opportunity
to select the optimal expression site for effective nutrition and
growth in distinct host environments [51]. Recombination can then
allow for VSG switching compatible with continued expression of
a favoured set of ESAGs.  The vast reservoir of VSG genes allows the
presentation of constantly changing epitopes at the cell surface to
counter the hosts’ capacity for adaptive immunity.
Access to genome sequence data changed the research land-
scape, allowing easy access to a vast number of VSG sequences,
factors involved in transcription, telomere-binding, recombina-
tion and repair and chromatin-based control. There has been an
inevitable focus on factors related to those with known functions
in other eukaryotes, however, meaning that a lot of territory still
remains uncharted in trypanosomatid research. Recent technical
advances in areas such as forward genetics [110], proteomics [111],
improved access to T. brucei developmental stages in in vitro cul-
ture [112] and new and improved technologies to come, will surely
now help to deliver answers to some of the outstanding questions.
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